Please Scroll Down to See Forums Below
Test male birth control??????????
- Thread starter slim09
- Start date
for most it drasticly lowers sperm count. This could be seen as a form of birth control however, this topic has been brought up before and there are plenty of bros who have concieved while on. I would not trust it, I had a pregnancy scare while on and have been more careful ever since.
Test, and most AAS, will reduce sperm count. There is no proof that it 100% ELIMINATES sperm totally. It only takes ONE SPERM to get a female pregnant.
If you want kids, then rely on it for BC.
If you want kids, then rely on it for BC.
Probably the least fun too! 
swordfish151
New member
riverrock said:
Forget that..i'll take my chances lol...
M
musclemuscle
Guest
test enth , as stated in anabolics 2005, could be used as a form of male birth control
Tweakle
New member
riverrock said:
LOL yeah. Speaking of deca those doctor approved BC progesterone implants are certainly a smart, sensible thing.. all the sides of deca and none of the benefits.
my gf misses her pill occasionally, I get a little peace of mind knowing that test&tren are a backup plan.. but I wouldn't rely on it as our primary BC
M
musclemuscle
Guest
Ulter said:
lol
thats what was stated
could be used as a form of male birth control
That's just plain irresponsible for them to write that. I was on enanthate and deca for FOUR YEARS and fathered a child. Ronnie Coleman has a daughter that is obviously his to look at her. This is a review of the current literature on the subject. The conclusion is that none of the methods of male contraception using hormones has been proven effective and should not be used as a clinical method of male contraception.
Contraception. 2005 Feb;71(2):89-94. Related Articles, Links
Steroid hormones for contraception in men: systematic review of randomized controlled trials.
Grimes DA, Gallo MF, Grigorieva V, Nanda K, Schulz KF.
Family Health International, P.O. Box 13950, Research Triangle Park, NC 27709, USA. [email protected]
Male hormonal contraception has been an elusive goal. Administration of sex steroids to men can shut off sperm production through effects on the pituitary and hypothalamus. However, this approach also decreases production of testosterone, so an "add-back" therapy is needed. We conducted a systematic review of all randomized controlled trials of male hormonal contraception and azoospermia. Few significant differences emerged from these trials. Levonorgestrel implants combined with injectable testosterone enanthate (100 mg im) were significantly more effective than was levonorgestrel 125 microg po daily combined with testosterone patches [10 mg/d; odds ratio (OR) for azoospermia with the oral levonorgestrel regimen, 0.03; 95% CI, 0.00-0.29]. The addition of levonorgestrel 500 microg po daily improved the effectiveness of testosterone enanthate 100 mg im weekly by itself (OR for azoospermia with the combined regimen, 4.0; 95% CI, 1.00-15.99). Several regimens, including testosterone alone and gonadotropin-releasing hormone agonists and antagonists, had disappointing results. In conclusion, no male hormonal contraceptive is ready for clinical use. All trials published to date have been small exploratory studies. As a result, their power to detect important differences has been limited and their results have been imprecise. In addition, the definition of oligospermia has been imprecise or inconsistent in many reports. To avoid bias, future trials need to pay more attention on the methodological requirements for randomized controlled trials. Trials with adequate power would also be helpful.
Contraception. 2005 Feb;71(2):89-94. Related Articles, Links
Steroid hormones for contraception in men: systematic review of randomized controlled trials.
Grimes DA, Gallo MF, Grigorieva V, Nanda K, Schulz KF.
Family Health International, P.O. Box 13950, Research Triangle Park, NC 27709, USA. [email protected]
Male hormonal contraception has been an elusive goal. Administration of sex steroids to men can shut off sperm production through effects on the pituitary and hypothalamus. However, this approach also decreases production of testosterone, so an "add-back" therapy is needed. We conducted a systematic review of all randomized controlled trials of male hormonal contraception and azoospermia. Few significant differences emerged from these trials. Levonorgestrel implants combined with injectable testosterone enanthate (100 mg im) were significantly more effective than was levonorgestrel 125 microg po daily combined with testosterone patches [10 mg/d; odds ratio (OR) for azoospermia with the oral levonorgestrel regimen, 0.03; 95% CI, 0.00-0.29]. The addition of levonorgestrel 500 microg po daily improved the effectiveness of testosterone enanthate 100 mg im weekly by itself (OR for azoospermia with the combined regimen, 4.0; 95% CI, 1.00-15.99). Several regimens, including testosterone alone and gonadotropin-releasing hormone agonists and antagonists, had disappointing results. In conclusion, no male hormonal contraceptive is ready for clinical use. All trials published to date have been small exploratory studies. As a result, their power to detect important differences has been limited and their results have been imprecise. In addition, the definition of oligospermia has been imprecise or inconsistent in many reports. To avoid bias, future trials need to pay more attention on the methodological requirements for randomized controlled trials. Trials with adequate power would also be helpful.
bigmann245
New member
Ulter said:
good read. thanks bro. i hate when guys thing they cant get their girl pregnant while on juice. yes the chances are less but like it was said before, it only takes one and you better hope its a good one if it does or your really in trouble. by good one i mean if you do get your girl pregnant you better pray it doesnt have a defects from that one sperm being bad. less sperm means more chances for a bad one getting through.
Ulter said:
Agreed
I cant believe that they would print something SO irrepsonsible as that
New hormone treatment acts as male contraceptive
By Christian Niedan, The Pitt News (U. Pittsburgh)
Published: Thursday, October 23, 2003
Article Tools: Page 1 of 2
(U-WIRE) PITTSBURGH - Men may soon be an injection away from temporarily not having to worry about impregnating their partners during sex.
A recent study, conducted by the ANZAC Research Institute in Australia, found that an injection of the hormone depot medroxyprogesteroneacetate, or DMPA, every three months inhibited male sperm production enough to qualify as reliable contraception.
The study, the results of which were published in the October issue of The Journal of Clinical Endocrinology and Metabolism, was conducted over five years and involved 55 couples, who experienced no pregnancies during the up-to-12-month period each man used the injection. Progestin is a synthetic form of the female sex hormone progesterone, which women produce to regulate their menstrual cycle.
While there were no major health side effects, according to study results, the progestin reduced the male sex drive along with sperm production, and testosterone had to be introduced into the body through hormone implants about once every four months to maintain previous libido.
After as much as a year of treatment, study participants stopped taking the injections and recovered previous sperm rates and sex drive.
ANZAC researchers said that, with the right hormonal balance, men taking such injections can achieve temporarily low sperm levels that are usually only possible through a vasectomy, the surgical form of male contraception that blocks sperm from reaching semen.
According to ANZAC, the regions of Australia and New Zealand where the study was conducted have the highest rate of vasectomy in the world.
ANZAC researchers say that by having an injection every few months, men can forget about the potential pregnancy hazard of their partners forgetting to take birth control pills. They added that it was up to pharmaceutical companies, who would pick up the results of the study, to decide which commercial form, pill or injection, the contraceptive would take.
By Christian Niedan, The Pitt News (U. Pittsburgh)
Published: Thursday, October 23, 2003
Article Tools: Page 1 of 2
(U-WIRE) PITTSBURGH - Men may soon be an injection away from temporarily not having to worry about impregnating their partners during sex.
A recent study, conducted by the ANZAC Research Institute in Australia, found that an injection of the hormone depot medroxyprogesteroneacetate, or DMPA, every three months inhibited male sperm production enough to qualify as reliable contraception.
The study, the results of which were published in the October issue of The Journal of Clinical Endocrinology and Metabolism, was conducted over five years and involved 55 couples, who experienced no pregnancies during the up-to-12-month period each man used the injection. Progestin is a synthetic form of the female sex hormone progesterone, which women produce to regulate their menstrual cycle.
While there were no major health side effects, according to study results, the progestin reduced the male sex drive along with sperm production, and testosterone had to be introduced into the body through hormone implants about once every four months to maintain previous libido.
After as much as a year of treatment, study participants stopped taking the injections and recovered previous sperm rates and sex drive.
ANZAC researchers said that, with the right hormonal balance, men taking such injections can achieve temporarily low sperm levels that are usually only possible through a vasectomy, the surgical form of male contraception that blocks sperm from reaching semen.
According to ANZAC, the regions of Australia and New Zealand where the study was conducted have the highest rate of vasectomy in the world.
ANZAC researchers say that by having an injection every few months, men can forget about the potential pregnancy hazard of their partners forgetting to take birth control pills. They added that it was up to pharmaceutical companies, who would pick up the results of the study, to decide which commercial form, pill or injection, the contraceptive would take.
